Opportunity
Simpler Grants.gov #FOR-FD-24-013
FDA Grant Opportunity for Development of Minor Use and Minor Species Animal Drugs (R01)
Buyer
Food and Drug Administration
Posted
November 30, 2023
Identifier
FOR-FD-24-013
NAICS
541714, 541715
This opportunity from the Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) supports the development of new animal drugs for minor uses in major species or for use in minor species (MUMS): - Government Buyer: - Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM) - Purpose and Scope: - Grants for research and development of new animal drugs intended for minor uses in major species or for use in minor species - Funding supports qualified safety and effectiveness testing required for FDA approval - Eligibility and Requirements: - Applicants must have an open Investigational New Animal Drug (INAD) file - Applicants must hold a minor use or minor species designation from FDA/CVM's Office of Minor Use and Minor Species Animal Drug Development (OMUMS) - Products/Services Requested: - Research and development services for MUMS-designated animal drugs - No specific OEMs, vendors, or part numbers are listed (this is a grant opportunity, not a product procurement) - Notable Details: - Funding instrument is a grant or cooperative agreement - Opportunity is focused on supporting the approval process for new animal drugs in underserved markets - Place of Performance: - Managed by the FDA; no specific delivery or performance location required
Description
This Notice of Funding Opportunity (NOFO) is issued by the Food and Drug Administration (FDA), Center for Veterinary Medicine (CVM), soliciting Research Project (R01) grant applications to develop or support the development of designated new animal drugs for minor uses in major species or for use in minor species (MUMS). Grants assist in defraying costs of qualified safety and effectiveness testing for FDA approval of MUMS-designated drugs. Eligible applicants include entities developing veterinary drugs or research partners, with specific requirements such as having an Investigational New Animal Drug (INAD) file and a minor use or minor species designation from FDA/CVM.